Current and Emerging Immune Checkpoint Targets for Immuno-Oncology Research eBook Request

Thank you for your interest in our Current and Emerging Immune Checkpoint Targets for Immuno-Oncology Research eBook.

• Different B7 family proteins and their effects on immune cell activation
• Members of the butyrophilin family of T cell co-stimulatory/co-inhibitory molecules
• The CD47-SIRP alpha myeloid cell-specific immune checkpoint pathway and how tumor cells can exploit this pathway to evade phagocytic destruction
• The effects of IDO/TDO and the kynurenine pathway on immune cell functions
• Different LAG-3 and TIM-3 ligands and how these ligand-receptor interactions can negatively regulate anti-tumor immune responses
• The immunosuppressive effects of the LILRB family
• The potential of CD96, PVRIG, TIGIT, and other VSTM and VSIG family proteins as next generation immuno-oncology targets
• Co-stimulatory members of the TNF receptor superfamily and their immunotherapeutic potential

Please also explore these additional immuno-oncology-related resources that we offer:

Immune Checkpoint Targets for Cancer Immunotherapy Research Poster

Application Note: A Simple Flow Cytometry-Based Assay for CAR Detection Using Fluorokines™

A Look Inside a Tumor: Mechanisms of Tumor Evasion and Immunosuppression in the Tumor Microenvironment poster

Webinar: Emerging Targets for Cancer Immunotherapy Research

Immunotherapy: Purified Proteins for Immunotherapy Research and Clinical Manufacturing

T Cell Co-Signaling Pathway: Ligand-Receptor Interactions

Blog: Targeting Myeloid-derived Suppressor Cells for Cancer Immunotherapy

Immune Cell Markers Interactive Resource Tool